Based on the described use of drugs affecting proteostasis as therapeutic strategies in cancer, HOOK1 could be a promising therapeutic target, since reducing this protein affects multiple cellular processes capable of triggering proteotoxic stress in tumor cells. This evidence concerns the gene HOOK1 and cancer.